FORA Capital’s PhenomeX Inc. Common Stock CELL Stock Holding History

FORA Capital’s Portfolio CELL Stock Details CELL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-28,788	Closed	-$563K	–	497
2021 Q3	$563K	Buy	+28,788	New	+$1.09M	0.14%	182

Other funds holding CELL

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

SUT

SC US (TTGP) Menlo Park, California $9.25B AUM 20.49% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

FORA Capital's CELL Position: Q4 2021 in Review

FORA Capital sold out of PhenomeX Inc. Common Stock (CELL) in Q4 2021, closing a stake of 28,788 shares — an estimated $563K sold.

FORA Capital first reported a position in CELL in Q3 2021 and held it in 1 quarter. The position peaked at $563K in Q3 2021. 132 funds tracked by Wall St. Rank hold CELL as of Q4 2021.

FORA Capital reported no remaining PhenomeX Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
FORA Capital sold 28,788 PhenomeX Inc. Common Stock shares in Q4 2021, an estimated $563K.
FORA Capital first reported a position in PhenomeX Inc. Common Stock in Q3 2021 and held it in 1 quarter.
FORA Capital's PhenomeX Inc. Common Stock position peaked at $563K in Q3 2021.
132 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q4 2021.

Based on FORA Capital's 13F filing for Q4 2021, filed 11 Feb 2022.